Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, No.36 Sanhao Street, Heping District, Shenyang, 110004, People's Republic of China.
Department of Obstetrics and Gynecology, Affiliated Hospital of Inner Mongolia Medical University, Huhehaote, 010050, People's Republic of China.
Arch Gynecol Obstet. 2022 Mar;305(3):651-659. doi: 10.1007/s00404-021-06347-6. Epub 2021 Nov 30.
This study aimed to investigate the effect of prophylactic uterine artery embolization (UAE) on reproductive outcomes in patients with cesarean scar pregnancy (CSP).
A retrospective case-control study was conducted using the hospital records of all women diagnosed with CSP during a period of 6 years, between January 2014 and December 2019, at Shengjing Hospital of China Medical University. The clinical characteristics and different treatment modalities were analyzed. According to the inclusion and exclusion criteria, 181 patients with reproductive needs were selected and divided into a UAE group (n = 51) and a non-UAE group (n = 130) according to whether they received preventive UAE before their hysteroscopic or laparoscopic operation. The basic characteristics and pregnancy outcomes of patients in each group were compared, and a propensity score-matched (PSM) analysis was used to produce 37 matched pairs.
Before PSM, the UAE group had a thinner muscle layer, larger mass size, and higher serum human chorionic gonadotropin level than the non-UAE group. The pregnancy rate and live birth rate of the UAE group were 54.9% and 61.9%, respectively, which were lower than those of the non-UAE group (61.5% and 66.7%), but no statistical differences were observed. Post-PSM, no significant differences between basic characteristics of the groups were observed. The pregnancy rate of the UAE group was 51.4%, which was lower than that of the non-UAE group (73.0%); the live birth rate of the UAE group was 64.3%, which was also lower than that of the non-UAE group (72.7%); however, the differences were not statistically significant with the P value of 0.077 and 0.716.
Prophylactic UAE did not induce a significant difference in pregnancy rate and live birth rate between the UAE group and the non-UAE group.
本研究旨在探讨预防性子宫动脉栓塞术(UAE)对剖宫产瘢痕妊娠(CSP)患者生殖结局的影响。
采用回顾性病例对照研究,收集 2014 年 1 月至 2019 年 12 月在中国医科大学盛京医院诊断为 CSP 的所有患者 6 年的病历资料。分析其临床特征及不同治疗方式。根据纳入和排除标准,选取 181 例有生育需求的患者,根据是否在宫腔镜或腹腔镜手术前行预防性 UAE 将其分为 UAE 组(n=51)和非 UAE 组(n=130)。比较两组患者的基本特征和妊娠结局,并采用倾向性评分匹配(PSM)分析产生 37 对匹配。
PSM 前,UAE 组的子宫肌层厚度较薄、孕囊体积较大、血清人绒毛膜促性腺激素水平较高。UAE 组的妊娠率和活产率分别为 54.9%和 61.9%,均低于非 UAE 组(61.5%和 66.7%),但差异无统计学意义。PSM 后,两组患者的基本特征差异无统计学意义。UAE 组的妊娠率为 51.4%,低于非 UAE 组(73.0%);活产率为 64.3%,亦低于非 UAE 组(72.7%),但差异均无统计学意义,P 值分别为 0.077 和 0.716。
预防性 UAE 并未显著改变 UAE 组与非 UAE 组的妊娠率和活产率。